Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-03-12-Speech-1-107"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20010312.7.1-107"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, just a couple of small points at the outset: clearly the Seattle Ministerial Conference failed to agree on a new round because developing countries refused to proceed with trade liberalisation. They made it clear that they did not feel that their concerns about the implementation of the Uruguay Round had been met and therefore they were not prepared to go any further. They were insisting, as they continue to do – as you know, Commissioner – on implementation.
Secondly, we need in this Parliament to be much more aware of the need to monitor international obligations, in particular since no reference has been made here today to the ACP-EU Cotonou Agreement and its agricultural trade protocols. The EU must be much more sensitive to these concerns than it has been in the past, though I pay tribute to the Commissioner, especially as regards access to markets.
Now I want to touch briefly on the rather shadowy side of globalisation which is typified for me by access to medicines and the clear need for a review of TRIPs. Eleven million people will die of preventable diseases this year. In Zambia, treatment of one member of a family for pneumonia will take up the family's entire monthly budget. This is of deep concern. As you are aware, the pharmaceutical companies have taken the South African Government to court about its Medicines Act of 1997. This act would allow parallel importing and would authorise the genetic production of patented medicines for the government's non-profit, non-commercial use. Four million people are HIV-infected in that country and the South African Government believes it has a constitutional duty to do this.
Would the Commissioner agree with me that the TRIPs is neutral on parallel imports and actually allows for compulsory licensing? And would he agree with me that there should be a reduction in patent protection, reinforced health safeguards and a ban on the threatened use of trade sanctions?"@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples